Patent · US Active

Piperidine inhibitors of Janus kinase 3

US8299084B2 · kind B2 · utility

10Cited by
23References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 20, 2010
Grant dateOct 30, 2012
Priority date
Expiry dateSep 7, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/55
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to new piperidine inhibitors of Janus kinase 3 activity, pharmaceutical compositions thereof, and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.